logo
ResearchBunny Logo
The efficacy and adverse events of conventional and second-generation androgen receptor inhibitors for castration-resistant prostate cancer: A network meta-analysis

Medicine and Health

The efficacy and adverse events of conventional and second-generation androgen receptor inhibitors for castration-resistant prostate cancer: A network meta-analysis

X. Zhang, G. Zhang, et al.

Discover the findings of an exciting network meta-analysis that uncovers the superior efficacy of second-generation androgen receptor inhibitors over conventional treatments for castration-resistant prostate cancer. This research was conducted by Xianlu Zhang, Gejun Zhang, Jianfeng Wang, Jianbin Bi, Xiaolan Deng, Yanlong Wang, and Yinu Wang.

00:00
Playback language: English
Abstract
This network meta-analysis compared the efficacy and adverse events of conventional (bicalutamide) and second-generation androgen receptor inhibitors (ARIs; enzalutamide, apalutamide, and darolutamide) in treating castration-resistant prostate cancer (CRPC). Seven randomized clinical trials (RCTs) involving 6,993 patients were analyzed. Second-generation ARIs were superior to bicalutamide in terms of progression-free survival (PFS), prostate-specific antigen (PSA) progression-free survival (PSA-PFS), and overall survival (OS). However, there were subtle differences among the second-generation ARIs; apalutamide showed a higher rate of Grade 3+ adverse events (AEs). All ARIs were generally well-tolerated.
Publisher
Frontiers in Endocrinology
Published On
Feb 10, 2023
Authors
Xianlu Zhang, Gejun Zhang, Jianfeng Wang, Jianbin Bi, Xiaolan Deng, Yanlong Wang, Yinu Wang
Tags
castration-resistant prostate cancer
androgen receptor inhibitors
network meta-analysis
bicalutamide
adverse events
progression-free survival
overall survival
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny